Bio Business

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

The state’s industry draws inspiration from medicine as well as agriculture.

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

How close are liquid biopsies to replacing current diagnostics?

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

Science-based tinnitus therapeutics are finally coming into their own.